# Kaneka acquires 96.8% of EndoStream Medical

Japan's Kaneka Corporation announced the acquisition of 96.8% of shares of Israeli medical device company EndoStream Medical, which develops the Nautilus device for aneurysm treatment. The deal is valued at an estimated $100 million, and Kaneka plans to jointly develop and manufacture new cerebrovascular devices, targeting over $120 million in sales by 2030.

- Type: Acquisition
- Announced: 2024-12-23
- Where: Or Akiva, Israel
- Value: $100.0M
- Status: completed
- Products: Nautilus aneurysm treatment device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Kaneka](https://endata.com/companies/5927.md) (acquirer)
- [EndoStream Medical](https://endata.com/companies/82209.md) (target)

## Sources

- [en.globes.co.il](https://en.globes.co.il/en/article-japans-kaneka-buys-israeli-co-endostream-medical-1001499004), 2025-01-09: "Japan's Kaneka Corporation has announced the acquisition of 96.8% of shares of Israeli medical device company EndoStream Medical Ltd. (ESM)."
- [neuronewsinternational.com](https://neuronewsinternational.com/kaneka-announces-acquisition-of-endostream-medical/), 2025-01-10: "Kaneka Corporation has announced that—on 23 December 2024—it acquired 96.8% of shares in Israeli medical equipment company Endostream Medical."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.